Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients.
Orthotopic heart transplant recipients need immunosuppressive treatment and are at an increased risk for opportunistic infections such as Malassezia folliculitis. During a 4-month period (July to October 1990), 11 such cases were identified and treated; all were male with mean age of 43+/-9 years and on standard triple immunosuppressive therapy. Skin scrapings in potassium hydroxide (KOH) preparation with microscopy and/or culture identified either Malassezia furfur or Malassezia pachydermatis as the etiologic agent. A treatment with topical preparation (clotrimazole 1% and selenium sulfide lotion) was effective in 6 patients, whereas the rest received systemic fluconazole treatment with satisfactory outcome; all lesions were resolved within 3 weeks. Fluconazole appears to be an effective agent with excellent therapeutic outcome when administered for 3 weeks.
Rhie
S
S
Department of Medicine, Temple University Health Sciences Center, School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Turcios
R
R
Buckley
H
H
Suh
B
B
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D005499:Folliculitis / Q000188:drug therapy* / Q000382:microbiology*; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D008290:Malassezia; D008297:Male; D008875:Middle Aged
D000935:Antifungal Agents; D015725:Fluconazole